SCHEMBL8414533

SCHEMBL8414533

CCCCOc1cccc(C(=O)C(=O)C2CCCCC2)c1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.57
LMNA P02545 1/20 0.57
ALOX12 P18054 1/20 0.57
HTT P42858 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
SMPD1 P17405 3/20 0.50
KMT2A Q03164 2/20 0.50
PLA2G4B P0C869 1/20 0.50
HPGD P15428 1/20 0.50
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
THRB P10828 2/20 0.49
NR1H4 Q96RI1 2/20 0.48
MEN1 O00255 1/20 0.47
THRA P10827 1/20 0.46
KAT6A Q92794 1/20 0.46
USP2 O75604 1/20 0.46
MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8190935 0.80 NR4A2 (0.60) SMPD1KMT2ANR1H4MEN1
SCHEMBL8414531 0.78 KMT2A (0.65) LMNAL3MBTL1SMPD1KMT2APLA2G4B
SCHEMBL8414532 0.77 KMT2A (0.59) LMNAL3MBTL1SMPD1KMT2APLA2G4B
SCHEMBL30016648 0.77 SMPD1 (0.74) SMPD1KMT2APLA2G4BTHRBNR1H4
SCHEMBL16196481 0.77 SMPD1 (0.74) SMPD1KMT2APLA2G4BTHRBNR1H4
SCHEMBL1436145 0.75 THRB (0.65) LMNASMPD1KMT2APLA2G4BHPGD
SCHEMBL3315904 0.75 KMT2A (0.84) SMPD1KMT2APLA2G4BNR1H4
SCHEMBL27903063 0.75 KMT2A (0.64) LMNAL3MBTL1SMPD1KMT2APLA2G4B
SCHEMBL31135466 0.75 KMT2A (0.56) LMNATDP1L3MBTL1SMPD1KMT2A
SCHEMBL31679681 0.75 KMT2A (0.56) LMNATDP1L3MBTL1SMPD1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007016012-A2 CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR β-SECRETASE MODULATION WYETH (US) 2007-02-08 WO disclosed
US-20070027199-A1 Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation WYETH (US) 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027199-A1 Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation BACE1, BACE2, APP KDM4E 1003/4885LMNA 1410/4885ALOX12 2340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.